KR20250111317A - 중추 신경계 손상 질환을 처치 또는 예방하기 위한 고리형 펩티드 유도체 조성물 - Google Patents

중추 신경계 손상 질환을 처치 또는 예방하기 위한 고리형 펩티드 유도체 조성물

Info

Publication number
KR20250111317A
KR20250111317A KR1020257017381A KR20257017381A KR20250111317A KR 20250111317 A KR20250111317 A KR 20250111317A KR 1020257017381 A KR1020257017381 A KR 1020257017381A KR 20257017381 A KR20257017381 A KR 20257017381A KR 20250111317 A KR20250111317 A KR 20250111317A
Authority
KR
South Korea
Prior art keywords
group
hydrogen atom
composition
mmol
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020257017381A
Other languages
English (en)
Korean (ko)
Inventor
고헤이 마츠모토
가이토 오니시
가나 데라가미
유마 가리타
시치다이 다나베
고스케 야스이
다케시 쇼스
Original Assignee
다이이치 고교 세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다이이치 고교 세이야쿠 가부시키가이샤 filed Critical 다이이치 고교 세이야쿠 가부시키가이샤
Publication of KR20250111317A publication Critical patent/KR20250111317A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020257017381A 2022-11-04 2023-11-01 중추 신경계 손상 질환을 처치 또는 예방하기 위한 고리형 펩티드 유도체 조성물 Pending KR20250111317A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2022-177714 2022-11-04
JP2022177714 2022-11-04
PCT/JP2023/039446 WO2024096066A1 (ja) 2022-11-04 2023-11-01 中枢神経系損傷疾患を処置または予防するための環状ペプチド誘導体組成物

Publications (1)

Publication Number Publication Date
KR20250111317A true KR20250111317A (ko) 2025-07-22

Family

ID=90930657

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020257017381A Pending KR20250111317A (ko) 2022-11-04 2023-11-01 중추 신경계 손상 질환을 처치 또는 예방하기 위한 고리형 펩티드 유도체 조성물

Country Status (7)

Country Link
EP (1) EP4613282A1 (https=)
JP (1) JPWO2024096066A1 (https=)
KR (1) KR20250111317A (https=)
CN (1) CN120152726A (https=)
IL (1) IL320606A (https=)
TW (1) TW202525320A (https=)
WO (1) WO2024096066A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202547546A (zh) * 2024-02-07 2025-12-16 日商第一工業製藥股份有限公司 用以改善腦功能之環狀肽衍生物組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172896A (en) 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
GB9217295D0 (en) 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
US5541231A (en) 1993-07-30 1996-07-30 Glaxo Wellcome Inc. Stabilized Pharmaceutical
GB9315856D0 (en) 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US5358970A (en) 1993-08-12 1994-10-25 Burroughs Wellcome Co. Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
DE69839355T2 (de) 1997-07-29 2009-06-04 Alcon Laboratories, Inc., Fort Worth Ophthalmische Zusammensetzungen enthaltend Galaktomannanpolymere und Borat
AU2483599A (en) 1998-01-29 1999-08-16 Sepracor, Inc. Pharmaceutical uses of optically pure (-)-bupropion
US8889112B2 (en) 1999-09-16 2014-11-18 Ocularis Pharma, Llc Ophthalmic formulations including selective alpha 1 antagonists
US6933289B2 (en) 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
EP1654002B2 (en) 2003-08-07 2014-01-29 Allergan, Inc. Compositions for delivery of therapeutics into the eyes
US20050059744A1 (en) 2003-09-12 2005-03-17 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
WO2016047638A1 (ja) * 2014-09-24 2016-03-31 国立大学法人岩手大学 環状ペプチド誘導体とその製造方法および組成物
JP7486328B2 (ja) * 2020-03-05 2024-05-17 株式会社バイオコクーン研究所 神経突起伸長促進剤、神経細胞の樹状突起発現促進剤、及び神経栄養因子様作用物質
JP7695662B2 (ja) * 2020-11-02 2025-06-19 公立大学法人大阪 環状ペプチド誘導体の製造方法及び環状ペプチド化合物の製造方法

Also Published As

Publication number Publication date
JPWO2024096066A1 (https=) 2024-05-10
TW202525320A (zh) 2025-07-01
WO2024096066A1 (ja) 2024-05-10
EP4613282A1 (en) 2025-09-10
IL320606A (en) 2025-07-01
CN120152726A (zh) 2025-06-13

Similar Documents

Publication Publication Date Title
AU2010295461B2 (en) Process for preparing azabicyclic compounds
JPH08508027A (ja) 金属タンパク加水分解酵素阻害剤である天然アミノ酸誘導体
JP2026016715A (ja) 狂犬病治療のための環状アミド化合物およびその方法
KR20250111317A (ko) 중추 신경계 손상 질환을 처치 또는 예방하기 위한 고리형 펩티드 유도체 조성물
KR20020016846A (ko) 4차 암모늄 유도체, 이의 제조 방법 및 약제학적 용도
KR20250112778A (ko) 신경 장애성 동통 및/또는 염증성 동통을 처치 또는 예방하기 위한 고리형 펩티드 유도체 조성물
KR20250044905A (ko) 고리형 펩티드 유도체와 그 제조 방법 및 조성물
WO2025169981A1 (ja) 脳機能を改善するための環状ペプチド誘導体組成物
WO2025169980A1 (ja) テストステロンの産生／分泌を調節するための環状ペプチド誘導体組成物
EP4595973A1 (en) Cyclic peptide derivative composition for treating or preventing eye disease
JPH09157236A (ja) フェニレンジアミン誘導体及びラジカルスカベンジャー、脳梗塞抑制剤、脳浮腫抑制剤
JP2023084946A (ja) 生理活性を有する新規化合物
JP2022091476A (ja) 新規含窒素三環性骨格化合物およびその使用
JP2023084944A (ja) 生理活性を有する新規化合物
JP2023542455A (ja) ３－デオキシ－２－ケトアルドン酸窒素含有誘導体、その製造方法及びその使用
CA2135211A1 (en) Indazol-3-one-2-yl derivatives of benzopyrans
JPH0967327A (ja) フェニレンジアミン誘導体及びラジカルスカベンジャー、脳梗塞抑制剤、脳浮腫抑制剤
JPWO2002006227A1 (ja) マトリックスメタロプロテアーゼ阻害活性化合物

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

Q12 Application published

Free format text: ST27 STATUS EVENT CODE: A-1-1-Q10-Q12-NAP-PG1501 (AS PROVIDED BY THE NATIONAL OFFICE)